These worksheets are free forever. Want lessons that adapt to your child as they learn, plus progress tracking? Try Ignition Learning free.

Sign up free

Ignition Learning — Activity Sheet

Performance-enhancing drugs & fair play in sport

Health & PE · Year 10

Name: ______________________Date: ____________

Performance-enhancing drugs (PEDs) are substances used to artificially improve athletic performance beyond what training and natural ability alone would achieve — their use is banned in most organised sport, and there's genuine, ongoing tension between different positions on whether and how strictly they should be prohibited. Arguments against PEDs often centre on fairness (an uneven playing field between users and non-users), health risks (many PEDs carry serious, sometimes long-term health consequences), and the integrity of what sport is meant to represent. Understanding equitable participation more broadly — ensuring group activities and competitive sport are genuinely accessible and fair for everyone involved, regardless of ability or background — connects to these same underlying values of fairness in sport.

Example

Anabolic steroid use in competitive sport is banned partly because of the health risks (including cardiovascular and hormonal effects) but also because of fairness — an athlete using steroids gains an artificial advantage unavailable to competitors who don't use them, undermining the basic premise that competition should primarily reward training, skill and natural ability.

Key terms

Performance-enhancing drug (PED):
A substance used to artificially improve athletic performance beyond training and natural ability.
Equitable participation:
Ensuring group and competitive activities are genuinely accessible and fair for everyone involved.

Questions

  1. 1. Performance-enhancing drugs (PEDs) are used to:

    • Artificially improve athletic performance
    • Have no effect on athletic performance at all
    • Only ever improve an athlete's mood
    • Replace the need for any training
  2. 2. PED use in organised sport is generally:

    • Banned
    • Fully encouraged with no restriction
    • Required for all professional athletes
    • Something with no rules or regulation at all
  3. 3. Arguments against PEDs often centre on:

    • Fairness, health risks and the integrity of sport
    • Nothing meaningful at all
    • Only the cost of the drugs, with no other consideration
    • Only their taste or appearance
  4. 4. PEDs can carry:

    • Serious, sometimes long-term health consequences
    • No health risk whatsoever
    • Only positive health effects
    • Effects unrelated to a person's health
  5. 5. Equitable participation in sport means:

    • Activities are genuinely accessible and fair for everyone involved
    • Only the most skilled people are ever allowed to participate
    • Participation is limited to a small, exclusive group
    • Fairness has no real role in sport
  6. 6. An athlete using steroids compared to one who doesn't gains:

    • An artificial advantage
    • No advantage of any kind
    • A disadvantage in every case
    • Something unrelated to competitive fairness
  7. 7. The debate over PEDs in sport is:

    • Genuinely ongoing, with tension between different positions
    • Something with no disagreement at all
    • Completely settled with no remaining debate
    • Irrelevant to how sport is organised
  8. 8. Why might banning PEDs be seen as protecting the basic premise of competitive sport, rather than just being an arbitrary rule?

    • If competition is meant to reward training, skill and natural ability, PEDs undermine that basic premise by introducing an artificial advantage
    • Banning PEDs has no real connection to what competitive sport is fundamentally meant to reward or represent
    • PED bans are completely arbitrary rules with no real connection to fairness or the nature of competition
    • PEDs and natural ability are always considered exactly equivalent contributors to athletic performance
  9. 9. Why might the health risks of PEDs be considered a separate concern from the fairness argument, even though both are often used to justify banning them?

    • Health risk relates to harm to the individual athlete, while fairness relates to the integrity of competition between athletes — two genuinely distinct considerations
    • Health risk and fairness are always exactly the same underlying concern with no meaningful distinction between them
    • Only one of these two considerations is ever actually relevant to justifying a ban on performance-enhancing drugs
    • The health risks of PEDs have no real connection to why they might be considered a problem in competitive sport
  10. 10. Why might equitable participation in a school sports activity require more than simply allowing everyone to sign up?

    • Genuine accessibility might also require considering things like skill-based groupings, adapted rules or support, so participation is meaningfully fair, not just technically open
    • Simply allowing everyone to sign up for an activity always guarantees genuinely equitable participation with nothing further required
    • Equitable participation has no connection to anything beyond whether people are technically permitted to join an activity
    • Skill-based groupings and adapted approaches never actually improve how equitable a sporting activity feels for participants
  11. 11. Why might some argue that PED regulations should be reconsidered for certain contexts (like adult recreational or masters competitions), even while opposing their use in elite or youth sport?

    • Different contexts can involve different stakes around fairness, health risk to developing bodies, and the broader integrity concerns tied to elite competition
    • The context or level of a sporting competition never has any bearing on how PED policy should be considered
    • PED policy debates only ever apply identically to every single level and context of sport with no possible distinction
    • There is never any legitimate argument for considering different PED policies across different sporting contexts
  12. 12. Why might drug testing programs in elite sport be considered an ongoing challenge, rather than a problem that has been fully solved?

    • New substances and methods of evading detection continue to emerge, requiring testing methods to keep adapting over time
    • Drug testing in elite sport was fully and permanently solved as soon as testing programs were first introduced
    • No new substances or methods for evading detection have ever emerged since testing programs began
    • The challenge of drug testing in sport has no real connection to the emergence of new substances or evasion methods
  13. 13. Why might an athlete who unknowingly consumes a banned substance (e.g. through a contaminated supplement) still face serious consequences under many sporting bodies' strict liability rules?

    • Strict liability policies place responsibility for what enters an athlete's body on the athlete themselves, partly to prevent claimed ignorance from becoming an easy way around anti-doping rules
    • Strict liability rules always guarantee that unintentional, accidental substance use faces no consequences whatsoever
    • An athlete's intent or awareness always fully determines whether any consequences apply under sporting anti-doping rules
    • Strict liability policies in sport have no real connection to preventing loopholes in anti-doping enforcement
  14. 14. Why might banning PEDs specifically in youth and junior sport be considered especially important, beyond the fairness concerns that also apply at the elite level?

    • Young, still-developing bodies can be particularly vulnerable to the health risks of PEDs, adding a developmental health concern on top of the usual fairness argument
    • Health risk considerations are always exactly identical for young, developing athletes and fully mature elite athletes
    • There is no meaningful additional reason to be concerned about PED use specifically among young or junior athletes
    • Youth and junior sport are never actually a context where performance-enhancing drug use has been a genuine concern
  15. 15. Why might the debate over PEDs in sport connect to broader philosophical questions about what we actually value in athletic achievement?

    • It raises deeper questions about whether we value overcoming natural limits through any means, or specifically value achievement through the fair, unassisted development of human ability
    • This debate has no genuine connection to any broader philosophical questions about the nature or purpose of athletic achievement
    • What we value in athletic achievement is always completely settled and universally agreed upon with no room for debate
    • PED policy is purely a technical and medical matter with no connection to values or philosophy at all
  16. 16. Why might genuinely equitable participation sometimes require treating people differently (like providing additional support or adapted rules for some participants), rather than treating everyone in an identical way?

    • True fairness can mean addressing different starting points or needs so that everyone has a genuinely comparable opportunity to participate meaningfully, not just technically identical treatment
    • Treating every participant in an absolutely identical way always guarantees genuinely equitable participation for everyone involved
    • Providing additional support or adapted approaches for some participants is always inherently unfair to everyone else
    • Equitable participation and identical treatment are always exactly the same thing with no meaningful distinction
  17. 17. Why might the tension between competitive drive (wanting to win) and fair play (respecting the rules and rights of others) be considered a genuinely difficult balance for many athletes, not just a simple choice?

    • Strong competitive motivation and consistently prioritising fairness can sometimes pull in different directions, especially under high pressure, making the balance a real, ongoing challenge
    • Competitive drive and fair play are always perfectly aligned with absolutely no possible tension between them
    • This balance is always trivially easy for every athlete to maintain, with no genuine difficulty involved
    • Fair play and the desire to win have no meaningful connection to each other in competitive sport
  18. 18. Why might the widespread use of PEDs by some competitors create pressure on other, initially clean athletes to also consider using them, even if they personally disagree with doing so?

    • If enough competitors gain an artificial advantage, the perceived cost of staying "clean" (falling behind) can create real pressure that spreads beyond the athletes who started using PEDs
    • Other athletes' choices about PED use never have any bearing on the decisions or pressures faced by their competitors
    • Widespread PED use among some competitors has no realistic effect on the broader culture or pressures within a sport
    • Athletes who choose not to use PEDs are always completely unaffected by decisions other competitors make
  19. 19. Why might some argue that certain legal performance aids (like specialised training facilities or advanced sports science support only available to wealthier athletes or nations) raise a similar fairness question to banned PEDs, even though they aren't prohibited?

    • Both scenarios involve unequal access to something that can improve performance, so some argue the fairness principle behind banning PEDs could logically extend to significant resource-based advantages too
    • Access to superior training facilities or resources never actually provides any competitive advantage in elite sport
    • Legal resource-based advantages and banned performance-enhancing drugs are always considered completely unrelated fairness issues with no meaningful comparison
    • There is no reasonable argument connecting the fairness concerns behind PED bans to unequal access to legal training resources
  20. 20. Why might sporting bodies invest heavily in anti-doping education for young athletes, not just testing at the elite level?

    • Building understanding of the risks and rules early can help shape attitudes and decision-making before an athlete ever reaches a level where PED use might feel like a realistic temptation
    • Anti-doping education for young athletes provides no genuine benefit compared to only testing at the elite level
    • Attitudes and decisions about PED use are always completely unrelated to any education received earlier in an athlete's development
    • Testing at the elite level alone is always considered fully sufficient for addressing PED use across a sport
  21. 21. Understanding performance-enhancing drugs and fair play in sport mainly helps you to:

    • Evaluate the fairness, health and integrity arguments shaping how sport is regulated
    • Assume all arguments about performance-enhancing drugs in sport are identical with no real distinctions
    • Ignore the connection between equitable participation and broader values of fairness in sport
    • Treat health risk and competitive fairness as exactly the same underlying concern with no real difference

Answer key (parent copy)

  1. 1. Artificially improve athletic performance
  2. 2. Banned
  3. 3. Fairness, health risks and the integrity of sport
  4. 4. Serious, sometimes long-term health consequences
  5. 5. Activities are genuinely accessible and fair for everyone involved
  6. 6. An artificial advantage
  7. 7. Genuinely ongoing, with tension between different positions
  8. 8. If competition is meant to reward training, skill and natural ability, PEDs undermine that basic premise by introducing an artificial advantage
  9. 9. Health risk relates to harm to the individual athlete, while fairness relates to the integrity of competition between athletes — two genuinely distinct considerations
  10. 10. Genuine accessibility might also require considering things like skill-based groupings, adapted rules or support, so participation is meaningfully fair, not just technically open
  11. 11. Different contexts can involve different stakes around fairness, health risk to developing bodies, and the broader integrity concerns tied to elite competition
  12. 12. New substances and methods of evading detection continue to emerge, requiring testing methods to keep adapting over time
  13. 13. Strict liability policies place responsibility for what enters an athlete's body on the athlete themselves, partly to prevent claimed ignorance from becoming an easy way around anti-doping rules
  14. 14. Young, still-developing bodies can be particularly vulnerable to the health risks of PEDs, adding a developmental health concern on top of the usual fairness argument
  15. 15. It raises deeper questions about whether we value overcoming natural limits through any means, or specifically value achievement through the fair, unassisted development of human ability
  16. 16. True fairness can mean addressing different starting points or needs so that everyone has a genuinely comparable opportunity to participate meaningfully, not just technically identical treatment
  17. 17. Strong competitive motivation and consistently prioritising fairness can sometimes pull in different directions, especially under high pressure, making the balance a real, ongoing challenge
  18. 18. If enough competitors gain an artificial advantage, the perceived cost of staying "clean" (falling behind) can create real pressure that spreads beyond the athletes who started using PEDs
  19. 19. Both scenarios involve unequal access to something that can improve performance, so some argue the fairness principle behind banning PEDs could logically extend to significant resource-based advantages too
  20. 20. Building understanding of the risks and rules early can help shape attitudes and decision-making before an athlete ever reaches a level where PED use might feel like a realistic temptation
  21. 21. Evaluate the fairness, health and integrity arguments shaping how sport is regulated